Literature DB >> 18027022

Small arteriovenous malformation of the common bile duct causing hemobilia in a patient with hereditary hemorrhagic telangiectasia.

Sadao Hayashi1, Yasutaka Baba, Kazuto Ueno, Masayuki Nakajo.   

Abstract

We report a 54-year-old male patient with arteriovenous malformation located at the common bile duct and hereditary hemorrhagic telangiectasia. The patient was treated as gallstone pancreatitis at first. Three days after endoscopic nasobiliary drainage (ENBD) for biliary drainage to subside gallstone pancreatitis, hemobilia was drained from the ENBD tube and the serum hemoglobin level gradually decreased. Cholangioscopy and angiography revealed that hemobilia was due to a small arteriovenous malformation located at the common bile duct. Subsequently, the patient was successfully treated by endovascular intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18027022     DOI: 10.1007/s00270-007-9098-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  5 in total

Review 1.  Peroral cholangioscopy in the new millennium.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

2.  Per-oral cholangioscopy.

Authors:  Amitabh Monga; Mohan Ramchandani; D Nageshwar Reddy
Journal:  J Interv Gastroenterol       Date:  2011-04

Review 3.  Current status of peroral cholangioscopy in biliary tract diseases.

Authors:  Stefania Ghersi; Lorenzo Fuccio; Marco Bassi; Carlo Fabbri; Vincenzo Cennamo
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

4.  Hemobilia from Biliary Angiodysplasia Diagnosed with Cholangioscopy.

Authors:  Kap Sum Foong; Ashley Lee; Shaismy Kudakachira; Hemchand Ramberan
Journal:  ACG Case Rep J       Date:  2016-09-28

Review 5.  Hemobilia caused by pancreatic arteriovenous malformation: A case report and literature review.

Authors:  Xiaolei Liu; Jia Huang; Haidong Tan; Zhiying Yang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.